PLYMOUTH, Minn.--(BUSINESS WIRE)--SpineThera, Inc., a leading clinical-stage pharmaceutical company specializing in innovative injectable drugs, is thrilled to announce groundbreaking results from an independent market research study. The study underscores the enormous potential of SpineThera's SX600, a novel formul...